The United States Food and Drug Administration considers GM crops to be “substantially equivalent” to their traditional counterparts. This means that they can be managed simply as commodities in this country. On the other hand, various sorts of labeling are required in many other countries, and so food companies doing business worldwide must comply with various regulations and have removed GM ingredients in countries with mandatory labeling requirements. These conflicts have led to turmoil in the national and international marketplace.